Ocular Findings in Patients with COVID-19: Impact on Eye Banking [Letter]

Loïc Hamon1 Department of Ophthalmology, Saarland University Medical Center (UKS), Homburg/Saar, GermanyCorrespondence[email protected]

Tarek Bayyoud2 Department of Ophthalmology, University of Tübingen, Tübingen, Germany

Berthold Seitz1 Department of Ophthalmology, Saarland University Medical Center (UKS), Homburg/Saar, Germany

References

Qu JY, Xie HT, Zhang MC. Evidence of SARS-CoV-2 transmission through the ocular route. Clin Ophthalmol. 2021;15:687–696. doi:10.2147/OPTH.S295283
PubMed Web of Science ®Google Scholar
Casagrande M, Fitzek A, Spitzer MS, et al. Presence of SARS-CoV-2 RNA in the cornea of viremic patients with COVID-19. JAMA Ophthalmol. 2021;139(4):383–388. doi:10.1001/jamaophthalmol.2020.6339
Web of Science ®Google Scholar
Bayyoud T, Iftner A, Iftner T, et al. Absence of severe acute respiratory syndrome coronavirus-2 RNA in human corneal tissues. Cornea. 2021;40(3):342–347. doi:10.1097/ICO.0000000000002479
Web of Science ®Google Scholar
Trigaux C, Salla S, Schroeter J, et al. SARS-CoV-2: impact on, risk assessment and countermeasures in German Eye Banks. Curr Eye Res. 2021;46(5):666–671. doi:10.1080/02713683.2020.1828487
Web of Science ®Google Scholar
Bayyoud T, Iftner T, Bartz-Schmidt KU, et al. First results of investigations of SARS-CoV-2 RNA in human corneal tissue. Ophthalmologe. 2021;118(S1):78–80. doi:10.1007/s00347-020-01254-8
Web of Science ®Google Scholar